HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide
Alessandro Canella(Nationwide Children's Hospital), Flavia Pichiorri(City Of Hope National Medical Center)
Cited by 43
Related Papers
CD84 is a regulator of the immunosuppressive microenvironment in multiple myeloma
|JCI Insight|2021|64
Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting
|bioRxiv (Cold Spring Harbor Laboratory)|2019|9